StonvexLoading…
StonvexCore line items from RDDT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $663.41M | $2.20B | $1.48B | $891.99M |
Operating Income | $182.91M | $441.98M | $210.16M | $71.61M |
Net Income | $203.98M | $529.72M | $278.12M | $115.45M |
EPS (Diluted) | $1.01 | $2.62 | $1.38 | $0.58 |
Total Assets | $3.48B | $3.24B | $2.88B | $2.63B |
Total Liabilities | $304.57M | $310.13M | $265.71M | $245.22M |
Cash & Equivalents | $1.37B | $953.57M | $911.65M | $734.06M |
Free Cash Flow OCF − CapEx | $311.16M | $684.17M | $420.53M | $237.43M |
Shares Outstanding | 202.52M | 202.11M | 201.66M | 200.68M |